Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.3 to v3.5.0. This reflects a system update and does not change the study data or page content.
    Difference
    0.0%
    Check dated 2026-03-25T07:00:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The record history now shows the new site revision label v3.4.3 and removes the previous v3.4.2 from the list. This reflects an updated platform version in the record history.
    Difference
    0.0%
    Check dated 2026-03-10T15:36:27.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page header/footer.
    Difference
    0.0%
    Check dated 2026-02-17T03:20:46.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 to the history; removed the government funding lapse notice and the prior v3.4.0 reference.
    Difference
    0.4%
    Check dated 2026-02-09T22:38:00.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page informing users that some information may not be up to date and transactions may not be processed. It also directs users to cc.nih.gov and opm.gov for current operating status.
    Difference
    0.3%
    Check dated 2026-02-02T20:52:07.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Adds a glossary display and color-coded highlights for additions (green) and deletions (red), and updates the revision label to v3.4.0. The No FEAR Act data wording is adjusted for capitalization.
    Difference
    0.5%
    Check dated 2026-01-26T21:04:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.